Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Frontiers in Genetics
|
October 7, 2024
Editorial: Epigenetic mechanisms and their involvement in rare diseases, volume II
Mojgan Rastegar
Frontiers in Genetics
|
November 13, 2024
Editorial: Epigenetic modification in neurological diseases
Mojgan Rastegar
Frontiers in Molecular Neuroscience
|
February 6, 2024
Editorial: New insights into the molecular mechanisms of autistic spectrum disorders
Mojgan Rastegar
Current Topics in Medicinal Chemistry
|
January 25, 2017
Editorial (Thematic Issue: NeuroEpigenetics and Neurodevelopmental Disorders: From Molecular Mechanisms to Cell Fate Commitments of the Brain Cells and Human Disease)
Mojgan Rastegar
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
May 24, 2020
Ubiquitin ligases and medulloblastoma: genetic markers of the four consensus subgroups identified through transcriptome datasets
Jerry Vriend, Mojgan Rastegar
Biomolecules
|
January 12, 2021
Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease
Shervin Pejhan, Mojgan Rastegar
Frontiers in Genetics
|
September 20, 2021
Editorial: Epigenetic Mechanisms and Their Involvement in Rare Diseases
Mojgan Rastegar, Dag H Yasui
Biology
|
May 12, 2026
Mechanistic Links Between DNA Methylation and Protein Translation and Their Impacts on Brain Development
Ashraf Kadar Shahib, Mojgan Rastegar
Neural Plasticity
|
April 5, 2012
Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research
Robby Mathew Zachariah, Mojgan Rastegar
Epigenomics
|
November 8, 2023
MeCP2 is the protector of epigenome integrity, membrane-less nuclear architecture, and stability of chromatin assembly
Mojgan Rastegar, James R Davie
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Frontiers in Genetics
|
October 7, 2024
Editorial: Epigenetic mechanisms and their involvement in rare diseases, volume II
Mojgan Rastegar
Frontiers in Genetics
|
November 13, 2024
Editorial: Epigenetic modification in neurological diseases
Mojgan Rastegar
Frontiers in Molecular Neuroscience
|
February 6, 2024
Editorial: New insights into the molecular mechanisms of autistic spectrum disorders
Mojgan Rastegar
Current Topics in Medicinal Chemistry
|
January 25, 2017
Editorial (Thematic Issue: NeuroEpigenetics and Neurodevelopmental Disorders: From Molecular Mechanisms to Cell Fate Commitments of the Brain Cells and Human Disease)
Mojgan Rastegar
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
May 24, 2020
Ubiquitin ligases and medulloblastoma: genetic markers of the four consensus subgroups identified through transcriptome datasets
Jerry Vriend, Mojgan Rastegar
Biomolecules
|
January 12, 2021
Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease
Shervin Pejhan, Mojgan Rastegar
Frontiers in Genetics
|
September 20, 2021
Editorial: Epigenetic Mechanisms and Their Involvement in Rare Diseases
Mojgan Rastegar, Dag H Yasui
Biology
|
May 12, 2026
Mechanistic Links Between DNA Methylation and Protein Translation and Their Impacts on Brain Development
Ashraf Kadar Shahib, Mojgan Rastegar
Neural Plasticity
|
April 5, 2012
Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research
Robby Mathew Zachariah, Mojgan Rastegar
Epigenomics
|
November 8, 2023
MeCP2 is the protector of epigenome integrity, membrane-less nuclear architecture, and stability of chromatin assembly
Mojgan Rastegar, James R Davie
Page
of 8